Fundraising FoxBiotech Startups
11,114 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Pelthos Therapeutics is a biopharmaceutical company that develops and commercializes topical treatments for infectious skin conditions and parasitic infestations. The company markets approved and pipeline therapeutic products targeting patient populations with limited treatment options.
0 investors
Novasenta is a biotechnology company that uses single-cell analysis of human tissue samples combined with computational biology to discover novel therapeutic targets and develop treatments for immune-mediated diseases and cancer.
0 investors
0 investors
Noveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
0 investors
0 investors
0 investors
Eledon Pharmaceuticals (formerly Novus Therapeutics) develops antibody-based therapies targeting the CD40 Ligand pathway for transplant organ protection and amyotrophic lateral sclerosis treatment, with tegoprubart as its lead clinical-stage candidate.
0 investors
0 investors
0 investors
Nu-Med Plus develops medical devices that generate and deliver nitric oxide gas for clinical, hospital, and research applications. The company's products—including formulations, bedside delivery systems for intensive care, portable rechargeable units, and laboratory research equipment—are designed to reduce the cost and improve the accessibility of nitric oxide therapy for treating conditions including hypoxia in newborns and potentially other diseases, pending FDA approval.
0 investors
Nuclein makes the DASH Rapid PCR System, a compact point-of-care diagnostic instrument that delivers lab-quality PCR test results in about 15 minutes from a single cartridge. It is used in clinics such as urgent care, pediatric, and primary care settings to test for multiple viruses during a patient visit.
0 investors
0 investors
0 investors
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
0 investors
Nutriband develops transdermal drug delivery systems and pharmaceutical products, with a focus on abuse-deterrent technology aimed at reducing misuse of opioid-based transdermal medications. It operates through subsidiaries covering clinical R&D, contract manufacturing, and sports recovery products.
0 investors
0 investors
NV Therapeutics develops non-viral gene therapies designed to be safe, effective, and scalable. The company targets a new generation of genetic treatments for disease.
0 investors
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
0 investors
0 investors
NXT Biomedical is a medical device incubator that develops and spins out startups building clinical medical technologies aimed at addressing unmet needs and reducing healthcare costs. It plans to invest $25 million over five years to create five to eight companies.
0 investors
0 investors
Objective Biotechnology develops neurotechnology tools for cortex-wide optical access and neural recordings in unrestrained rodent models, along with automated microinjection systems for large-scale genetic manipulation and embryo microinjection. Its products serve researchers working with biological systems.
0 investors